This summer, physicians, scientists, and trainees came together for the inaugural UC San Francisco Central Nervous System Metastasis Symposium.
Every year, the American Brain Tumor Association (ABTA) brings together patients, caregivers, and survivors to learn about latest advances in brain tumor research, treatment, and care.
Scientists know some viral infections can cause cancer later in life. Now, researchers at the UCSF Brain Tumor Center have identified a link between the genetic risk factors for glioma and the immune response to certain common viruses.
While various immunotherapies work through different mechanisms, they are all designed to enhance the immune system’s ability to recognize and target cancer cells. Pembrolizumab does so by binding and inhibiting PD-1, a protein that normally protects the body from attacking itself.
The newly released 2021 WHO Classification of Tumors of the Central Nervous System (CNS) introduces major changes that advance the role of molecular profiling in CNS tumor classification and includes ma